In vitro data revealed that increased ST6GAL1 expression promoted CRC cell proliferation, migration, and chemoresistance, findings further supported by transcriptomic and glycosylation modification sequencing data. This evidence concerns the gene ST6GAL1 and colorectal carcinoma.